Latest From Medscape UK
For You: Latest News & Resources
News
The roles of the nervous system and the gut microbiome need to be more carefully considered when treating gastrointestinal disorders, say experts.
News
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every 2 months.
Clinical Summary
Clinical Summary
Clinical Summary
Clinical Summary
Clinical Summary
Clinical Summary